0001650840-17-000002.txt : 20170426
0001650840-17-000002.hdr.sgml : 20170426
20170425194534
ACCESSION NUMBER: 0001650840-17-000002
CONFORMED SUBMISSION TYPE: D
PUBLIC DOCUMENT COUNT: 1
ITEM INFORMATION: 06b
FILED AS OF DATE: 20170426
DATE AS OF CHANGE: 20170425
EFFECTIVENESS DATE: 20170426
FILER:
COMPANY DATA:
COMPANY CONFORMED NAME: Dance Biopharm Holdings, Inc.
CENTRAL INDEX KEY: 0001650840
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: D
SEC ACT: 1933 Act
SEC FILE NUMBER: 021-285483
FILM NUMBER: 17782251
BUSINESS ADDRESS:
STREET 1: 150 NORTH HILL DRIVE, SUITE 24
CITY: BRISBANE
STATE: CA
ZIP: 94005
BUSINESS PHONE: 415-369-9415
MAIL ADDRESS:
STREET 1: 150 NORTH HILL DRIVE, SUITE 24
CITY: BRISBANE
STATE: CA
ZIP: 94005
FORMER COMPANY:
FORMER CONFORMED NAME: Dance BioPharm Holdings, Inc.
DATE OF NAME CHANGE: 20150812
D
1
primary_doc.xml
X0707
D
LIVE
0001650840
Dance Biopharm Holdings, Inc.
150 NORTH HILL DRIVE, SUITE 24
BRISBANE
CA
CALIFORNIA
94005
415-369-9415
DELAWARE
SAV Holdings Corp.
Dance BioPharm Holdings, Inc.
Corporation
true
2013
John
S.
Patton, Ph.D
150 North Hill Drive, Suite 24
Brisbane
CA
CALIFORNIA
94005
Executive Officer
Director
Donald
D.
Huffman
150 North Hill Drive, Suite 24
Brisbane
CA
CALIFORNIA
94005
Executive Officer
Director
Lisa
E.
Porter, M.D.
150 North Hill Drive, Suite 24
Brisbane
CA
CALIFORNIA
94005
Executive Officer
Vivian
Yan
150 North Hill Drive, Suite 24
Brisbane
CA
CALIFORNIA
94005
Director
Steven
Thornton
150 North Hill Drive, Suite 24
Brisbane
CA
CALIFORNIA
94005
Director
Adam
K.
Stern
c/o Aegis Capital Corp.
810 Seventh Ave., 18th Floor
New York
NY
NEW YORK
10019
Director
Biotechnology
Decline to Disclose
- 06b
false
2017-04-07
false
true
true
true
false
15000
Aegis Capital Corp
15007
None
None
810 Seventh Avenue, 18th Floor
New York
NY
NEW YORK
10019
All States
false
5000000
837604
4162396
false
5
500000
true
0
Placement Agent is entitled to receive 10% cash and expense fees. Assumes maximum offering sold. Does not include value of warrants issuable to Placement Agent
0
true
Proceeds to be used as working capital, including payment of officer and employee salaries. A portion of the proceeds to be used to compensate Placement Agent. Adam Stern, a director of the issuer, is an affiliate of the Placement Agent.
false
Dance Biopharm Holdings, Inc.
/s/John S. Patton Ph.D
John S. Patton Ph.D
Chief Executive Officer
2017-04-25